- Home
- FOLD vs SPHR Comparison
FOLD vs SPHR Comparison
Compare FOLD & SPHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- SPHR
- Stock Information
- Founded
- FOLD 2002
- SPHR 2020
- Country
- FOLD United States
- SPHR United States
- Employees
- FOLD N/A
- SPHR N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- SPHR Services-Misc. Amusement & Recreation
- Sector
- FOLD Health Care
- SPHR Consumer Discretionary
- Exchange
- FOLD Nasdaq
- SPHR Nasdaq
- Market Cap
- FOLD 2.5B
- SPHR 2.1B
- IPO Year
- FOLD 2007
- SPHR N/A
- Fundamental
- Price
- FOLD $8.15
- SPHR $59.85
- Analyst Decision
- FOLD Strong Buy
- SPHR Buy
- Analyst Count
- FOLD 9
- SPHR 8
- Target Price
- FOLD $26.44
- SPHR $53.25
- AVG Volume (30 Days)
- FOLD 5.8M
- SPHR 1.3M
- Earning Date
- FOLD 11-05-2025
- SPHR 11-11-2025
- Dividend Yield
- FOLD N/A
- SPHR N/A
- EPS Growth
- FOLD N/A
- SPHR N/A
- EPS
- FOLD N/A
- SPHR N/A
- Revenue
- FOLD $571,160,000.00
- SPHR $1,040,932,000.00
- Revenue This Year
- FOLD $20.98
- SPHR $9.94
- Revenue Next Year
- FOLD $20.74
- SPHR $9.84
- P/E Ratio
- FOLD N/A
- SPHR N/A
- Revenue Growth
- FOLD 25.35
- SPHR 1.37
- 52 Week Low
- FOLD $5.51
- SPHR $23.89
- 52 Week High
- FOLD $12.65
- SPHR $68.00
- Technical
- Relative Strength Index (RSI)
- FOLD 56.40
- SPHR 57.77
- Support Level
- FOLD $7.69
- SPHR $62.14
- Resistance Level
- FOLD $8.59
- SPHR $68.00
- Average True Range (ATR)
- FOLD 0.37
- SPHR 3.01
- MACD
- FOLD -0.05
- SPHR -0.24
- Stochastic Oscillator
- FOLD 54.44
- SPHR 28.69
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments which includeSphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.